Bots, editor, reviewer, Administrators
13,951
edits
WikiJournalClub:Usable articles: Difference between revisions
Jump to navigation
Jump to search
no edit summary
No edit summary |
No edit summary |
||
| Line 158: | Line 158: | ||
'''Mitral Regurgitation''' | '''Mitral Regurgitation''' | ||
* [[MIDA]] (2013): Early surgery for MR | * [[MIDA]] (2013): Early surgery for MR | ||
'''Myeloproliferative Neoplasms''' | |||
* [[CYTO-PV]] (2013): Hematocrit thresholds in PV | |||
'''Myocardial Infarction''' | '''Myocardial Infarction''' | ||
| Line 188: | Line 191: | ||
'''Peripheral Vascular Disease''' | '''Peripheral Vascular Disease''' | ||
* [[HPS2-THRIVE]] (2014): Niacin in atherosclerotic disease | * [[HPS2-THRIVE]] (2014): Niacin in atherosclerotic disease | ||
'''Polycythemia Vera''' | |||
* [[CYTO-PV]] (2013): Hematocrit thresholds in PV | |||
'''Pulmonary Embolism''' | '''Pulmonary Embolism''' | ||
| Line 510: | Line 516: | ||
* [[Ibrutinib in Waldenstrom macroglobulinemia]] (2015): Second-line ibrutinib in WM | * [[Ibrutinib in Waldenstrom macroglobulinemia]] (2015): Second-line ibrutinib in WM | ||
* [[StiL]] (2013): BR vs. R-CHOP for indolent lymphomas | * [[StiL]] (2013): BR vs. R-CHOP for indolent lymphomas | ||
'''Myeloproliferative Neoplasms''' | |||
* [[CYTO-PV]] (2013): Hematocrit thresholds in PV | |||
'''Polycythemia Vera''' | |||
* [[CYTO-PV]] (2013): Hematocrit thresholds in PV | |||
'''Pulmonary Embolism''' | '''Pulmonary Embolism''' | ||
| Line 606: | Line 618: | ||
'''Chronic Kidney Disease''' | '''Chronic Kidney Disease''' | ||
* [[ACE Inhibitors in Severe CKD]] (2006): ACE-inhibitor in advanced non-DM CKD | |||
* [[CHOIR]] (2006): EPO in CKD with anemia | * [[CHOIR]] (2006): EPO in CKD with anemia | ||
* [[EVOLVE]] (2012): Cinacalcet in ESRD | * [[EVOLVE]] (2012): Cinacalcet in ESRD | ||